Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
5.21 EUR | -0.95% | +13.26% | -37.60% |
2023 | Biosynex: merger with Theradiag completed | CF |
2023 | Biosynex SA Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Sales 2021 | 383M 409M | Sales 2022 | 197M 210M | Capitalization | 141M 151M |
---|---|---|---|---|---|
Net income 2021 | 104M 111M | Net income 2022 | 15M 16.02M | EV / Sales 2021 | 0.5 x |
Net cash position 2021 | 96.72M 103M | Net cash position 2022 | 35.09M 37.49M | EV / Sales 2022 | 0.54 x |
P/E ratio 2021 |
2.63
x | P/E ratio 2022 |
9.08
x | Employees | 551 |
Yield 2021 |
7.6% | Yield 2022 |
-
| Free-Float | 39.43% |
1 day | -3.04% | ||
1 week | +10.87% | ||
Current month | +5.92% | ||
1 month | +8.28% | ||
3 months | -37.04% | ||
6 months | -41.78% | ||
Current year | -38.92% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Lamy
FOU | Founder | - | 05-03-14 |
Larry Abensur
CEO | Chief Executive Officer | 69 | 05-03-14 |
Thierry Paper
FOU | Founder | 60 | 05-03-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Thierry Paper
FOU | Founder | 60 | 05-03-14 |
Thomas Lamy
FOU | Founder | - | 05-03-14 |
Larry Abensur
CEO | Chief Executive Officer | 69 | 05-03-14 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 5.21 | -0.95% | 8 215 |
24-04-22 | 5.26 | +3.14% | 6,526 |
24-04-19 | 5.1 | 0.00% | 5,290 |
24-04-18 | 5.1 | -2.30% | 11,754 |
24-04-17 | 5.22 | +13.48% | 57,237 |
Real-time Euronext Paris, April 23, 2024 at 04:46 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-38.92% | 60.25M | |
+1.19% | 12.66B | |
-17.03% | 7.04B | |
+1.73% | 4.32B | |
-2.51% | 4.45B | |
-50.32% | 3.31B | |
+6.90% | 2.6B | |
-16.54% | 2.01B | |
-3.40% | 1.67B | |
-6.24% | 1.45B |
- Stock Market
- Equities
- ALBIO Stock